StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $1.99. The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01. The company has a market cap of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.66.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- Stock Market Sectors: What Are They and How Many Are There?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What Are the U.K. Market Holidays? How to Invest and Trade
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- How to start investing in penny stocks
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
